Skip to main content

Table 1 Baseline characteristics

From: In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

Characteristic

rFSH

hMG-HP

All Patients

Number of cycles

   

All patients N (%)

22665 (74%)

7965 (26%)

30630

≤35 years N (%)

15422 (75%)

5142 (25%)

20564

≥36 years N (%)

7243 (72%)

2823 (28%)

10066

Age Mean (SD)

32.89 (3.57)

33.04 (3.71)1,2

32.93 (3.61)

  1. 1 p < 0.01 in Wilcoxon two sample test
  2. 2 p < 0.01 in two sample t-test
Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us